Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
COM
Compatibility of
A
Commonly Used
Intravenous
Drugs
ll
ri
py
ts
Co
gh
ri
re
gh
se
rv
du
ct
i
ib
d.
t e ro h
no s p
e
i
is
n
rw sio
is
he
ot rm
ss
pe
le ut
un ho
up wit
ro
G art
ng n p
i
hi
r
is
bl e o
Pu ol
h
on w
ah in
cM on
i
ro
ep
09
.R
20
ed
he number of available IV
te
d.
I N D E P E N D E N T LY D E V E L O P E D B Y M C M A H O N P U B L I S H I N G
P H A R M AC Y P R AC T I C E N E WS S E P T E M B E R 2 0 0 9
ll
Acyclovir
ri
Amikacin
Gentamicin
Argatroban
re
se
rv
09
.R
gh
ed
Bumetanide
Calcium gluconate
Cefazolin
Cefepime
ro
Cefotaxime
du
Cefotetan
Ceftazidime
Ceftizoxime
Ceftriaxone
Ciprofloxacin
Clindamycin
Dexamethasone
D5W
Diazepam
20
Bivalirudin
ep
N
N
C
Diltiazem
Diphenhydramine
Dobutamine
Dolasetron
Dopamine
Doripenem
Doxycycline
Enalaprilat
Epinephrine
Eptifibatide
Esmolol
Esomeprazole
Famotidine
Fentanyl
Fluconazole
Furosemide
Gatifloxacin
i
ib
d.
t e ro h
no s p
e
i
is
n
rw sio
is
he
ot rm
ss
pe
le ut
un ho
up wit
ro
G art
ng n p
i
hi
r
is
bl e o
Pu ol
h
on w
ah in
cM on
i
ct
C
C
N
I
C
te
d.
KEY
A = Physically compatible for at least 2 hours
C = Physically compatible
I = Incompatible
N = Information on compatibility is not available or conflicting
Gatifloxacin
C
C
Ampicillin-sulbactam
Furosemide
Fluconazole
Fentanyl
Famotidine
Esomeprazole
Esmolol
Eptifibatide
Epinephrine
Enalaprilat
Doxycycline
Doripenem
Dopamine
Dolasetron
Dobutamine
Diphenhydramine
Diltiazem
Diazepam
Dextrose 5% in water
Dexamethasone
Clindamycin
Ciprofloxacin
Ceftriaxone
Ceftizoxime
Ceftazidime
Cefotetan
Cefotaxime
Cefepime
Cefazolin
Calcium gluconate
Bumetanide
Bivalirudin
Aztreonam
I
N
Aztreonam
Azithromycin
C
I
Azithromycin
Argatroban
Ampicillin-sulbactam
Ampicillin
Ampicillin
(continued)
ri
py
ts
Co
gh
Amiodarone
Amiodarone
Amikacin
Acyclovir
I N D E P E N D E N T LY D E V E L O P E D B Y M C M A H O N P U B L I S H I N G
I
I
I
C
Morphine sulfate
Nafcillin
Nitroglycerin
Nitroprusside
Acyclovir
Amikacin
Amiodarone
ll
ri
gh
Phenytoin
Phenylephrine
Pantoprazolea
N
Ondansetron
I
Norepinephrine
N
Heparin
Vasopressin
Midazolam
Vancomycin
Metronidazole
TMP-SMX
Metoclopramide
Tobramycin
Tigecycline
Meropenem
Ticarcillin-clavulanate
Mannitol
Magnesium sulfate
Sodium bicarbonate
Lorazepam
Ringers, lactated
Linezolid
Propofol
Levofloxacin
Prochlorperazine
Labetalol
Potassium chloride
Insulin, regular
Piperacillin-tazobactam
Imipenem-cilastatin
Penicillin G Potassium
Hydromorphone
Granisetron
Co
Ampicillin
Ampicillin-sulbactam
Argatroban
Azithromycin
Aztreonam
Bivalirudin
ep
09
Bumetanide
se
rv
ed
.R
20
gh
re
ri
py
ts
Calcium gluconate
Cefazolin
Cefepime
Cefotaxime
ct
Cefotetan
Ceftazidime
Ceftizoxime
Ceftriaxone
Ciprofloxacin
Clindamycin
Dexamethasone
D5W
Diazepam
Diltiazem
Diphenhydramine
Dobutamine
Dolasetron
Dopamine
Doripenem
Doxycycline
Enalaprilat
Epinephrine
Eptifibatide
Esmolol
Esomeprazole
Famotidine
Fentanyl
Fluconazole
Furosemide
Gatifloxacin
du
i
ib
d.
t e ro h
no s p
e
i
is
n
rw sio
is
he
ot rm
ss
pe
le ut
un ho
up wit
ro
G art
ng n p
i
hi
r
is
bl e o
Pu ol
h
on w
ah in
cM on
i
ro
te
d.
I N D E P E N D E N T LY D E V E L O P E D B Y M C M A H O N P U B L I S H I N G
P H A R M AC Y P R AC T I C E N E WS S E P T E M B E R 2 0 0 9
Ampicillin
Ampicillin-sulbactam
Argatroban
Azithromycin
Aztreonam
Bivalirudin
Bumetanide
Calcium gluconate
Cefazolin
Cefepime
Cefotaxime
Cefotetan
Ceftazidime
Ceftizoxime
Ceftriaxone
Ciprofloxacin
Clindamycin
Dexamethasone
Dextrose 5% in water
Diazepam
Diltiazem
Diphenhydramine
Dobutamine
Dolasetron
Dopamine
Doripenem
Doxycycline
Enalaprilat
Epinephrine
Eptifibatide
Esmolol
Esomeprazole
Famotidine
Fentanyl
Fluconazole
Furosemide
Gatifloxacin
ri
Imipenem-cilastatin
Insulin, regular
gh
ll
Granisetron
py
ts
Co
gh
Heparin
Hydrocortisone
ri
re
Hydromorphone
Gentamicin
Amiodarone
Gentamicin
Amikacin
(continued)
Acyclovir
se
Linezolid
Lorazepam
Magnesium sulfate
ro
Mannitol
Meropenem
Methylprednisolone
Metoclopramide
Metronidazole
Midazolam
Morphine sulfate
Nafcillin
Nitroglycerin
Nitroprusside
Norepinephrine
Ondansetron
Pantoprazolea
Penicillin G
Phenylephrine
Phenytoin
i
ib
d.
t e ro h
no s p
e
i
is
n
rw sio
is
he
ot rm
ss
pe
le ut
un ho
up wit
ro
G art
ng n p
i
hi
r
is
bl e o
Pu ol
h
on w
ah in
cM on
i
du
Piperacillan-tazobactam I
ct
ep
09
20
Labetalol
ed
Levofloxacin
.R
rv
Potassium chloride
Prochlorperazine
Propofol
Ringers, lactated
Sodium bicarbonate
Ticarcillin-clavulanate
Tigecycline
Tobramycin
TMP-SMX
Vancomycin
Vasopressin
te
d.
I N D E P E N D E N T LY D E V E L O P E D B Y M C M A H O N P U B L I S H I N G
Vasopressin
Vancomycin
TMP-SMX
Tobramycin
Tigecycline
Ticarcillin-clavulanate
Sodium bicarbonate
Ringers, lactated
Propofol
Prochlorperazine
Potassium chloride
Piperacillin-tazobactam
Phenytoin
Phenylephrine
Penicillin G Potassium
Pantoprazolea
Ondansetron
Norepinephrine
Nitroprusside
Nitroglycerin
Nafcillin
Morphine sulfate
Midazolam
Metronidazole
Metoclopramide
Meropenem
Mannitol
Magnesium sulfate
Lorazepam
Linezolid
Levofloxacin
Labetalol
Gentamicin
Granisetron
Heparin
py
ts
Insulin, regular
Imipenem-cilastatin
Hydromorphone
C
gh
ri
Co
ll
Heparin
Granisetron
Hydrocortisone
Hydromorphone
Imipenem-cilastatin
Insulin, regular
Labetalol
Levofloxacin
.R
Linezolid
ep
09
Lorazepam
Magnesium sulfate
Mannitol
Meropenem
Methylprednisolone
Metoclopramide
Metronidazole
Midazolam
Morphine sulfate
Nafcillin
Nitroglycerin
Nitroprusside
Norepinephrine
Ondansetron
Pantoprazolea
Penicillin G
Phenylephrine
Phenytoin
Piperacillin-tazobactam
Potassium chloride
Prochlorperazine
Propofol
Ringers, lactated
Sodium bicarbonate
Ticarcillin-clavulanate
Tigecycline
Tobramycin
TMP-SMX
Vancomycin
ct
i
ib
d.
t e ro h
no s p
e
i
is
n
rw sio
is
he
ot rm
ss
pe
le ut
un ho
up wit
ro
G art
ng n p
i
hi
r
is
bl e o
Pu ol
h
on w
ah in
cM on
i
du
ro
20
ed
gh
rv
se
ri
re
Vasopressin
te
d.
I N D E P E N D E N T LY D E V E L O P E D B Y M C M A H O N P U B L I S H I N G
P H A R M AC Y P R AC T I C E N E WS S E P T E M B E R 2 0 0 9
Three types of incompatibilities are commonly discussed: physical, chemical, and therapeutic. Physical
incompatibilities are the most easily detected and are
evidenced by visible changes such as particulate formation, haze, precipitation, color change, or gas evolution. Chemical incompatibilities are those that result
in decomposition of a drug. Loss of potency of greater
than 10% over the defined testing period is considered
chemical incompatibility. Most chemical incompatibilities can be detected only with a suitable analytic
method. Therapeutic incompatibilities, in which a drug
combination results in undesirable antagonistic or synergistic pharmacologic activity, are beyond the scope of
most compatibility references.
Despite the differing nature of compatibilities, the
type of incompatibility or compatibility is not specified in this chart. A designation of compatible indicates that the combination evaluated appears to be
Suggested Readings
ll
ri
py
ts
Co
gh
ri
re
se
gh
DRUGDEX System (Intranet database). Version 5.1. Greenwood Village, CO: Thomson Healthcare.
rv
du
ct
i
ib
d.
t e ro h
no s p
e
i
is
n
rw sio
is
he
ot rm
ss
pe
le ut
un ho
up wit
ro
G art
ng n p
i
hi
r
is
bl e o
Pu ol
h
on w
ah in
cM on
i
ro
ep
09
.R
20
ed
Trissel LA, ed. Handbook on Injectable Drugs. 15th ed. Bethesda, MD:
American Society of Health-System Pharmacists; 2009.
te
d.
I N D E P E N D E N T LY D E V E L O P E D B Y M C M A H O N P U B L I S H I N G